FibroGen Correlations
| FGENDelisted Stock | USD 9.71 0.69 7.65% |
The current 90-days correlation between FibroGen and Kezar Life Sciences is -0.08 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FibroGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FibroGen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
FibroGen Correlation With Market
Significant diversification
The correlation between FibroGen and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and DJI in the same portfolio, assuming nothing else is changed.
FibroGen |
Moving together with FibroGen Stock
| 0.81 | DOX | Amdocs | PairCorr |
| 0.78 | KG | Kestrel Group Symbol Change | PairCorr |
| 0.74 | MSFT | Microsoft | PairCorr |
| 0.72 | HPQ | HP Inc | PairCorr |
Moving against FibroGen Stock
| 0.8 | JNJ | Johnson Johnson | PairCorr |
| 0.8 | TRV | The Travelers Companies | PairCorr |
| 0.72 | PFE | Pfizer Inc | PairCorr |
| 0.67 | DD | Dupont De Nemours | PairCorr |
| 0.66 | XOM | Exxon Mobil Corp | PairCorr |
| 0.61 | VZ | Verizon Communications | PairCorr |
| 0.58 | LION | Lionsgate Studios Holding | PairCorr |
| 0.56 | WMT | Walmart Common Stock | PairCorr |
| 0.5 | CUB | Lionheart Holdings | PairCorr |
| 0.48 | CAT | Caterpillar | PairCorr |
| 0.44 | AA | Alcoa Corp | PairCorr |
| 0.42 | BAC | Bank of America Earnings Call This Week | PairCorr |
| 0.38 | MMM | 3M Company | PairCorr |
| 0.33 | IBM | International Business | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between FibroGen Stock performing well and FibroGen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze FibroGen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KZR | 1.91 | 0.79 | 0.83 | 0.98 | 0.00 | 1.66 | 54.12 | |||
| TPST | 4.74 | (1.62) | 0.00 | (2.09) | 0.00 | 7.92 | 60.86 | |||
| ALGS | 4.34 | 0.28 | 0.04 | 4.95 | 5.06 | 10.16 | 25.33 | |||
| OKUR | 4.06 | (0.05) | (0.01) | 0.01 | 4.50 | 7.53 | 23.27 | |||
| MRSN | 7.36 | 4.12 | 0.82 | (0.47) | 2.26 | 6.86 | 210.61 | |||
| XFOR | 3.68 | 0.43 | 0.11 | 0.29 | 3.80 | 9.63 | 36.44 | |||
| PDSB | 3.87 | (0.02) | 0.02 | 0.07 | 4.31 | 8.60 | 27.78 | |||
| CELU | 3.85 | (0.75) | 0.00 | (0.46) | 0.00 | 10.29 | 26.97 | |||
| XLO | 2.25 | (0.27) | 0.00 | (0.15) | 0.00 | 4.69 | 15.41 | |||
| ATNM | 3.43 | (0.08) | (0.01) | 0.02 | 3.42 | 8.05 | 25.17 |
| The entity FibroGen with a symbol FGEN was recently relisted or delisted. You can potentially use KYNB New with a symbol KYNB. Please make sure the ticker renaming or change in the classification of FibroGen is not a temporary action by the exchange. |
FibroGen Corporate Management
| Kirk MBA | Chief Officer | Profile | |
| Rahul Kaushik | Technical Development | Profile | |
| Mr JD | Chief Officer | Profile | |
| Enrique Conterno | CEO Director | Profile | |
| Barry Berkowitz | Founder | Profile | |
| Christine Chung | Senior Operations | Profile |
Still Interested in FibroGen?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.